Your browser doesn't support javascript.
loading
Bioequivalence study of pramipexole hydrochloride tablets in Chinese healthy subjects / 中国临床药理学与治疗学
Chinese Journal of Clinical Pharmacology and Therapeutics ; (12): 190-195, 2021.
Article Dans Chinois | WPRIM | ID: wpr-1015084
ABSTRACT

AIM:

To assess the bioequivalence of pramipexole hydrochloride tablets with reference(Sifrol).

METHODS:

A randomized, open-label, 2-period crossover study was conducted in 48 healthy Chinese volunteers under fasted or fed conditions (24 volunteers for each condition). In each session, the subjects received a single oral dose of 0.25 mg test (T) or reference (R) formulation. Pramipexole concentrations in plasma were determined by a validated HPLC-MS/MS. Pharmacokinetic parameters were calculated using a non-compartmental model through Phoenix WinNonlin version 6.4. Other statistic analysis were analyzed by using software of SAS 9.3.

RESULTS:

The pharmacokinetic parameters of test drug and reference drug under fasted condition(n=20) were C

Texte intégral: Disponible Indice: WPRIM (Pacifique occidental) langue: Chinois Texte intégral: Chinese Journal of Clinical Pharmacology and Therapeutics Année: 2021 Type: Article

Documents relatifs à ce sujet

MEDLINE

...
LILACS

LIS

Texte intégral: Disponible Indice: WPRIM (Pacifique occidental) langue: Chinois Texte intégral: Chinese Journal of Clinical Pharmacology and Therapeutics Année: 2021 Type: Article